Ads
related to: side effects of diabetes type 2 medications listoakstreethealth.com has been visited by 100K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The American Diabetes Association and the American College of Physicians both recommend metformin as a first-line agent to treat type 2 diabetes. [34] [35] [36] It is as effective as repaglinide and more effective than all other oral drugs for type 2 diabetes. [37]
SGLT2 inhibitor. SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney ), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption ...
Diabetes medication. Drugs used in diabetes treat diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin, most GLP-1 receptor agonists ( liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic ...
Alpha-glucosidase inhibitors ( AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar ). Carbohydrates are normally converted into simple sugars ( monosaccharides) by alpha-glucosidase enzymes present on cells lining the intestine, enabling ...
Empagliflozin, sold under the brand name Jardiance, among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. [10] [2] [12] It is taken by mouth. [2] Common side effects include hyperventilation, anorexia, abdominal pain, nausea, vomiting, lethargy, mental status changes, hypotension, acute ...
Dipeptidyl peptidase-4 inhibitor. Inhibitors of dipeptidyl peptidase 4 ( DPP-4 inhibitors or gliptins) are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2 . The first agent of the class – sitagliptin – was approved by the FDA in 2006.
Ads
related to: side effects of diabetes type 2 medications listoakstreethealth.com has been visited by 100K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month